Cargando…
CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model
Background: Before the discovery of cuproptosis, copper-loaded nanoparticle is a wildly applied strategy for enhancing the tumor-cell-killing effect of chemotherapy. Although copper(ii)-related researches are wide, details of cuproptosis-related bioprocess in pan-cancer are not clear yet now, especi...
Autores principales: | Wan, Hong, Yang, Xiaowei, Sang, Guopeng, Ruan, Zhifan, Ling, Zichen, Zhang, Mingzhao, Liu, Chang, Hu, Xiangyang, Guo, Tao, He, Juntong, Liu, Defeng, Pei, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637804/ https://www.ncbi.nlm.nih.gov/pubmed/37857018 http://dx.doi.org/10.18632/aging.205125 |
Ejemplares similares
-
Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer
por: Zhou, Cankun, et al.
Publicado: (2022) -
Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set
por: Liu, Hengrui, et al.
Publicado: (2022) -
Construction of a risk model and prediction of prognosis and immunotherapy based on cuproptosis-related LncRNAs in the urinary system pan-cancer
por: Ma, Zhihui, et al.
Publicado: (2023) -
Artificial intelligence reveals dysregulation of osteosarcoma and cuproptosis-related biomarkers, PDHA1, CDKN2A and neutrophils
por: Jiang, Jie, et al.
Publicado: (2023) -
Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
por: Bu, Fanqin, et al.
Publicado: (2023)